Patient-Focused Drug Development Tracker
The US Food and Drug Administration's patient-focused drug development program is poised to overhaul how drugs are approved for rare and inadequately served diseases and conditions. This tracker provides an in-depth look at what questions FDA is asking of patients and their representatives.
- See more at: http://www.raps.org/focus-online/news.aspx#sthash.RAzvnbVq.dpuf
No comments:
Post a Comment